Brought to you by 
Ricerca licenses antibacterials IP from Lilly
27 Dec 2002
Executive Summary
Eli Lilly has licensed Ricerca Biosciences LLC (contract services for drug development, plus in-licensed projects in cancer and infectious disease) exclusive worldwide rights to certain targets, patents, and know-how from its small-molecule antibacterials programs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ricerca licenses antibacterials IP from Lilly
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice